SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-001873
Filing Date
2022-02-24
Accepted
2022-02-24 16:47:56
Documents
2
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4107
2 SHANE OLWILL POA solwillpoa.txt EX-24 3320
  Complete submission text file 0001562180-22-001873.txt   8915
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109
Business Address
Olwill Shane (Reporting) CIK: 0001875416 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 22671893